Results 11 to 20 of about 1,796,626 (255)
Radionuclide Small Intestine Imaging [PDF]
Gastroenterology Research and Practice, 2013 The aim of this overview article is to present the current possibilities of radionuclide scintigraphic small intestine imaging. Nuclear medicine has a few methods—scintigraphy with red blood cells labelled by means of Tc99m for detection of the source of
Jiri Dolezal, Marcela Kopacova
doaj +2 more sources
RADIONUCLIDE IMAGING AND THERAPY OF NEUROENDOCRINE TUMOURS [PDF]
Journal of Cancer and Allied Specialties, 2015 The incidence and prevalence of neuroendocrine tumours (NETs) are on the rise. Although NETs are a heterogeneous group of tumours, they have some similar properties, for example, that they can concentrate neuroamines and tend to have a high degree of ...
Shaunak Navalkissoor +1 more
doaj +2 more sources
Radionuclide Imaging of Invasive Fungal Disease in Immunocompromised Hosts. [PDF]
Diagnostics (Basel), 2021 Invasive fungal disease (IFD) leads to increased mortality, morbidity, and costs of treatment in patients with immunosuppressive conditions. The definitive diagnosis of IFD relies on the isolation of the causative fungal agents through microscopy ...
Lawal IO +6 more
europepmc +3 more sources
Introduction to radionuclide therapy
, 2008 This introductory chapter is written for those who are new to the field and desire a short overview of the present status of clinical and preclinical radionuclide therapy. In particular, this chapter provides an overview of the radiophysical concepts and
Carlsson, Jörgen,
core +9 more sources
Pharmacoscintigraphy: Advancing Nanotheranostic Development Through Radionuclide Imaging
Journal of NanotheranosticsPharmacoscintigraphy has emerged as an essential tool in the research and development of nanomedicines, particularly in the field of nanotheranostics.
María Jimena Salgueiro +4 more
doaj +2 more sources
Application of the Linear-Quadratic model to targeted radionuclide therapy [PDF]
, 2011 PhDThe principal aim of this work was to test the hypothesis that the Linear-Quadratic (LQ) model of cell survival, developed for external beam radiotherapy (EBRT), could be extended to targeted radionuclide therapy (TRT) in order to predict dose ...
Murray, Iain
core +4 more sources
World Journal of Nuclear Medicine, 2020 Prostate-specific membrane antigen (PSMA) is a Type II transmembrane glycoprotein which is extremely overexpressed in prostate cancer epithelial cells. Recently, PSMA-targeted small molecule labeled with 68Ga and 99mTc allowed precise molecular imaging ...
Esmail Jafari +3 more
doaj +1 more source
Radioprotective Effect of Beta D-Glucan and Vitamin E on Gamma Irradiated Mouse [PDF]
Journal of Clinical and Diagnostic Research, 2017 Introduction: It is shown that beta-D-glucan is an immunologic system booster with radioprotectory effects. Radioprotectors are chemical components that can alleviate biological damage produced by ionizing radiation.
Faraj Tabeie +3 more
doaj +1 more source
Radionuclides for Targeted Therapy: Physical Properties
Molecules, 2022 A search in PubMed revealed that 72 radionuclides have been considered for molecular or functional targeted radionuclide therapy. As radionuclide therapies increase in number and variations, it is important to understand the role of the radionuclide and ...
Caroline Stokke +2 more
doaj +1 more source
Frontiers in Oncology, 2021 BackgroundProstate-specific membrane antigen (PSMA) targeting radioligands have transformed treatment of prostate cancer. Radioligand therapy (RLT) with 177Lu-PSMA in metastasized castration resistant prostate cancer (mCRPC) achieves objective response ...
Vikas Prasad +9 more
doaj +1 more source